Metyrosine treatment in a woman with chromosome 22q11.2 deletion syndrome and psychosis: a case study

References

• Aman, M. G. and Singh, N. N. 1986. Aberrant behavior checklist: manual. East Aurora, NY: Slosson Educational Publications.
   Google Scholar
• Angelopoulos, E., Theleritis, C. and Papageorgiou, C. C. 2017. Antipsychotic treatment of 22q11.2 deletion syndrome-related psychoses. Pharmacopsychiatry, 50, 162–163.
   PubMed Web of Science ®Google Scholar
• Bakken, T. L., Eilertsen, D. E., Smeby, N. A. and Martinsen, H. 2008. Effective communication related to psychotic disorganised behaviour in adults with intellectual disability and autism. Nordic Journal of Nursing Research, 28, 9–13.10.1177/010740830802800203
   Google Scholar
• Bakken, T. L., Friis, S., Lovoll, S., Smeby, N. A. and Martinsen, H. 2007. Behavioral disorganisation as an indicator of psychosis in adults with intellectual disability and autism. Mental Health Aspects of Developmental Disabilities, 10, 37–46.
   Google Scholar
• Bakken, T. L., Sageng, H., Hellerud, J. M. A., Kildahl, A. N. and Kristiansen, T. 2017. The use of validation in mental health nursing for adults with intellectual disabilities and mental illness: a descriptive study. Issues in Mental Health Nursing, 38, 619–623.10.1080/01612840.2017.1330910
   PubMed Web of Science ®Google Scholar
• Bhakta, S. G., Zhang, J.-P. and Malhotra, A. K. 2012. The COMT Met158 allele and violence in schizophrenia: a meta-analysis. Schizophrenia Research, 140, 192–197.10.1016/j.schres.2012.06.026
   PubMed Web of Science ®Google Scholar
• Boot, E., Butcher, N. J., Vorstman, T. A. M. J., Fung, W. L. A. and Bassett, A. S. 2015. Pharmacological treatment of 22Q11.2 deletion syndrome-related psychoses. Pharmacopsychiatry, 48, 219–220.
   PubMed Web of Science ®Google Scholar
• Carandang, C. G. and Scholten, M. C. 2007. Metyrosine in psychosis associated with 22q11.2 deletion syndrome: case report. Journal of Child and Adolescent Psychopharmacology, 17, 115–120.10.1089/cap.2006.0013
   PubMed Web of Science ®Google Scholar
• Dori, N., Green, T., Weizman, A. and Gothelf, D. 2017. The effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q11.2 deletion syndrome. Journal of Child and Adolescent Psychopharmacology, 27, 83–90.10.1089/cap.2014.0075
   PubMed Web of Science ®Google Scholar
• Graf, W. D., Unis, A. S. and Yates, C. M. 2001. Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism. Neurology, 57, 410–416.10.1212/WNL.57.3.410
   PubMed Web of Science ®Google Scholar
• Grati, F. R., Gomes, D. M., Ferreira, J. C. P. B. and Dupont, C. 2015. Prevalence of recurrent pathogenetic microdeletions and microduplications in over 9500 pregnancies. Prenatal Diagnosis, 35, 801–809.10.1002/pd.v35.8
   PubMed Web of Science ®Google Scholar
• Grossman, M. H., Emanuel, B. S. and Budarf, M. L. 1992. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2. Genomics, 12, 822–825.10.1016/0888-7543(92)90316-K
   PubMed Web of Science ®Google Scholar
• Hurley, A. D. 1996. The misdiagnosis of hallucinations and delusions in persons with mental retardation: A neurodevelopmental perspective. Seminars in Clinical Neuropsychiatry, 1, 122–133.
   PubMedGoogle Scholar
• Hosák, L. 2007. Role of the COMT gene Val158Met polymorphism in mental disorders: a review. European Psychiatry, 22, 276–281.10.1016/j.eurpsy.2007.02.002
   PubMed Web of Science ®Google Scholar
• Kates, W. R., Tang, K. L., Antshel, K. M. and Fremont, W. P. 2015. Behavioral and psychiatric Phenotypes in 22q11.2 deletion syndrome. Journal of Developmental & Behavioral Pediatrics, 36, 639–650.
   PubMed Web of Science ®Google Scholar
• Kay, S. R., Fiszbein, A. and Opler, L. A. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261–276.10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• Lin, C. E., Hwang, K. S., & Hsieh, P. H. (2009). Treatment of schizophreniform disorder by aripiprazole in a female adolescent with 22q11.2 deletion syndrome. Case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34, 1141–1143.
   Web of Science ®Google Scholar
• Matsumoto, M., Weickert, C. S., Kolachana, B., Chen, J., Hyde, T. M., Herman, M. M., Weinberger, D. R. and Kleinman, J. E. 2003. Cathecol O-metythyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology, 28, 1521–1530.10.1038/sj.npp.1300218
   PubMed Web of Science ®Google Scholar
• McDonald-McGinn, D. M., Sullivan, K. E., Mariano, B., Philip, N., Swillen, A., Vorstman, J .A. S., Zackai, E. H., Emanuel, B. S., Vermeesch, J. R., Morrow, B. E., Scambler, P. J., and Bassett, A. S. 2016. 22q11.2 deletion syndrome. Nature Reviews Disease Primers, 1:15071.
   Web of Science ®Google Scholar
• McFarlane, W. R., Dixon, L. and Lukens, E. 2003. Family psychoeducation and schizophrenia: a review of the literature. Journal of Marital and Family Therapy, 29, 223–245.10.1111/j.1752-0606.2003.tb01202.x
   PubMed Web of Science ®Google Scholar
• Monks, S., Niarchou, M., Davies, A. R., Walters, J. T., Williams, N., Owen, M. J., van den Bree, M. B. and Murphy, K. C. 2014. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophrenia Research, 153, 231–236.10.1016/j.schres.2014.01.020
   PubMed Web of Science ®Google Scholar
• Perry, R. R., Keiser, H. R., Norton, J. A., Wall, R. T., Robertson, C. N., Travis, W., Walther, M. M. and Linchor, W. M. 1990. Surgical management of pheochromocytoma with the use of metyrosine. Annals of Surgery, 212, 621–628.10.1097/00000658-199011000-00010
   PubMed Web of Science ®Google Scholar
• Schneider, M., Debbané, M., Bassett, A. S., Chow, E. W. C., Fung, W. L. A., van den Bree, M. B., Owen, M., Murphy, K. C., Niarchou, M., Kates, W. R. and Antshel, K. M. 2014. Psychiatric disorders from childhood to adulthood in 22q11.s deletion syndrome: Results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. The American Journal of Psychiatry, 171, 627–639.10.1176/appi.ajp.2013.13070864
   PubMed Web of Science ®Google Scholar
• Tveter, A. L., Bakken, T. L., Bramness, J. G. and Røssberg, J. I. 2014. Adjustment of the UKU side effect rating scale for adults with intellectual disabilities. A pilot study. Advances in Mental Health and Intellectual Disabilities, 8, 260–267.10.1108/AMHID-11-2013-0064
   Google Scholar
• van Os, J. and Kapur, S. 2009. Schizophrenia. The Lancet, 374, 635–645.10.1016/S0140-6736(09)60995-8
   PubMed Web of Science ®Google Scholar
• Verhoeven, W. M. A. and Egger, J. I. M. 2015. Atypical antipsychotics and relapsing psychoses in 22q11.2 deletion syndrome; a long-term evaluation of 28 patients. Pharmacopsychiatry, 48, 104–110.
   PubMed Web of Science ®Google Scholar
• Young, A. S., Shashi, V., Schoch, K., Kwapil, T. and Hooper, S. R. 2011. Discordance in diagnoses and treatment of psychiatric disorders in children and adolescents with 22q11.2 deletion syndrome. Asian Journal of Psychiatry, 4, 119–124. doi:10.1016/j.ajp.2011.03.002
   PubMedGoogle Scholar